Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome

Abstract Acute respiratory distress syndrome (ARDS) is a devastating hypoxemic respiratory failure, characterized by disruption of the alveolar-capillary membrane barrier. Current management for ARDS remains supportive, including lung-protective ventilation and a conservative fluid strategy. Mesench...

Full description

Bibliographic Details
Main Authors: Jibin Han, Yuxiang Liu, Hong Liu, Yuanyuan Li
Format: Article
Published: BMC 2019-12-01
Series:Stem Cell Research & Therapy
Online Access: